Lot certificates published
Plain, secure packaging
Purely Peptides
Research Catalog
Home/Certificates of Analysis

Certificates of Analysis

Results reported for submitted samples, with their testing scope and original certificates. The listed reports do not cover every catalog product or establish results for every vial.

Scanning a label opens its recorded lot URL. Compare the lot in our record with the lot printed on the certificate; any unresolved distinction stays with the results.

14 lots published; additional certificates are listed with their existing lots.

BPC-157 10mg

Lot in our record: BPC-20260828-01 · Certificate COA8895

Issued 2026-09-08

Bioviridian Inc. · COA8895

Reported identity
BPC-157
LC-MS/MS
Measured content / assay
10.63 mg
HPLC Quantitation
Chromatographic purity
99.74%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

GHK-CU 100mg

Lot in our record: GHK-20260828-01 · Certificate COA8897

Issued 2026-09-08

Bioviridian Inc. · COA8897

Reported identity
GHK-Cu
LC-MS/MS
Measured content / assay
103.58 mg
HPLC Quantitation
Chromatographic purity
99.68%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

KLOW 80mg

Lot in our record: KLW-20260828-01 · Certificate COA8896

Issued 2026-09-08

Bioviridian Inc. · COA8896

Reported identity
KPV, GHK-Cu, BPC-157, TB-500
LC-MS/MS
Measured content / assay
10.44, 50.21, 10.61, 10.39 mg
HPLC Quantitation
The document lists named components and multiple content values, but does not explicitly label each value with a component. Their comma order does not establish a mapping. Values remain unassigned.
Chromatographic purity
99.75%
RP-HPLC (214 nm)
The single Overall Purity value applies only as reported for the blend. Individual component purities are not reported.

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

KPV 10mg

Lot in our record: KPV-20260828-01 · Certificate COA8899

Issued 2026-09-08

Bioviridian Inc. · COA8899

Reported identity
KPV
LC-MS/MS
Measured content / assay
10.83 mg
HPLC Quantitation
Chromatographic purity
99.74%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

MOTS-c 10mg

Lot in our record: MOT-20260828-01 · Certificate COA8898

Issued 2026-09-08

Bioviridian Inc. · COA8898

Reported identity
MOTS-c
LC-MS/MS
Measured content / assay
10.74 mg
HPLC Quantitation
Chromatographic purity
99.84%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

Semaglutide 30mg

Lot in our record: SEM-20260828-01 · Certificate COA8900

Issued 2026-09-08

2 additional laboratory results for this lot

Bioviridian Inc. · COA8900

Reported identity
Semaglutide
LC-MS/MS
Measured content / assay
31.38 mg
HPLC Quantitation
Chromatographic purity
99.78%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Additional laboratory results (2)

Krause Analytical LLC · sample muz22ts · Lab #214175

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code muz22ts. We list this result under lot SEM-20260828-01.

Chromatographic purity
98.8%
Method: HPLC-UV/MS
Measured content
32.3 mg
Method: HPLC-UV-MS
Identity (mass spectral match)
ID Confirmed
Method: HPLC-UV-MS
Label claim
30 mg
% of label, as printed
107.8
COC#
145871
Received
2026-09-18
Analyzed
2026-09-25
Report issued
2026-10-01
Laboratory address
8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director
Mark C. Krause
PDF SHA-256
5eb1ffa5d911590d5bc29e05ed565ae05c9aa686243d94cd1e26985ce38efb21
Original full certificate (PDF) · muz22ts

Krause Analytical LLC · sample tes8zb2 · Lab #214174

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code tes8zb2. We list this result under lot SEM-20260828-01.

Chromatographic purity
98.6%
Method: HPLC-UV/MS
Measured content
33.4 mg
Method: HPLC-UV-MS
Identity (mass spectral match)
ID Confirmed
Method: HPLC-UV-MS
Label claim
30 mg
% of label, as printed
111.5
COC#
145871
Received
2026-09-18
Analyzed
2026-09-25
Report issued
2026-10-01
Laboratory address
8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director
Mark C. Krause
PDF SHA-256
ef454a2fb5468879a483654c6467965589e6edcf60eeca408874d536ec400d6d
Original full certificate (PDF) · tes8zb2
Read report detailsOriginal certificate (PDF)

Semax 30mg

Lot in our record: SMX-20260828-01 · Certificate COA8894

Issued 2026-09-08

Bioviridian Inc. · COA8894

Reported identity
Semax
LC-MS/MS
Measured content / assay
30.72 mg
HPLC Quantitation
Chromatographic purity
99.78%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

Tesamorelin 10mg

Lot in our record: TSM-20260828-01 · Certificate COA8893

Issued 2026-09-08

Bioviridian Inc. · COA8893

Reported identity
Tesamorelin
LC-MS/MS
Measured content / assay
10.35 mg
HPLC Quantitation
Chromatographic purity
99.74%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

GLOW 70mg

Lot in our record: BBG-20260811-01 · Certificate COA7917

Issued 2026-08-23

Bioviridian Inc. · COA7917

Reported identity
GHK-Cu, BPC-157, TB-500
LC-MS/MS
Measured content / assay
50.43, 10.72, 10.26 mg
HPLC Quantitation
The document lists named components and multiple content values, but does not explicitly label each value with a component. Their comma order does not establish a mapping. Values remain unassigned.
Chromatographic purity
99.84%
RP-HPLC (214 nm)
The single Overall Purity value applies only as reported for the blend. Individual component purities are not reported.

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

Retatrutide 15mg

Lot in our record: RET-20260811-02 · Certificate COA7918

Issued 2026-08-23

Bioviridian Inc. · COA7918

Reported identity
Retatrutide
LC-MS/MS
Measured content / assay
15.19 mg
HPLC Quantitation
Chromatographic purity
99.68%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

Retatrutide 30mg

Lot in our record: RET-20260811-01 · Certificate COA7920

Issued 2026-08-23

2 additional laboratory results for this lot

Bioviridian Inc. · COA7920

Reported identity
Retatrutide
LC-MS/MS
Measured content / assay
30.88 mg
HPLC Quantitation
Chromatographic purity
99.82%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Additional laboratory results (2)

Krause Analytical LLC · sample ksytstq · Lab #214171

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code ksytstq. We list this result under lot RET-20260811-01.

Chromatographic purity
99.3%
Method: HPLC-UV/MS
Measured content
28.7 mg
Method: HPLC-UV-MS
Identity (mass spectral match)
ID Confirmed
Method: HPLC-UV-MS
Label claim
30 mg
% of label, as printed
95.6
COC#
145871
Received
2026-09-18
Analyzed
2026-09-25
Report issued
2026-10-01
Laboratory address
8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director
Mark C. Krause
PDF SHA-256
af3a211da9ed8c4006d539d0a59c80b37fd79bbecd45ae2020083ad70869055c
Original full certificate (PDF) · ksytstq

Krause Analytical LLC · sample xbhwgh9 · Lab #214170

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code xbhwgh9. We list this result under lot RET-20260811-01.

Chromatographic purity
>99.9%
Method: HPLC-UV/MS
Measured content
28.0 mg
Method: HPLC-UV-MS
Identity (mass spectral match)
ID Confirmed
Method: HPLC-UV-MS
Label claim
30 mg
% of label, as printed
93.3
COC#
145871
Received
2026-09-18
Analyzed
2026-09-25
Report issued
2026-10-01
Laboratory address
8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director
Mark C. Krause
PDF SHA-256
30dddd9387a1b8b06b344b260b345b5a1f1180741773a332d849fee6725c2713
Original full certificate (PDF) · xbhwgh9
Read report detailsOriginal certificate (PDF)

Semaglutide 10mg

Lot in our record: SEM-20260811-01 · Certificate COA7919

Issued 2026-08-23

Bioviridian Inc. · COA7919

Reported identity
Semaglutide
LC-MS/MS
Measured content / assay
10.34 mg
HPLC Quantitation
Chromatographic purity
99.78%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

Tirzepatide 30mg

Lot in our record: TIR-20260811-02 · Certificate COA7922

Issued 2026-08-23

Bioviridian Inc. · COA7922

Reported identity
Tirzepatide
LC-MS/MS
Measured content / assay
30.60 mg
HPLC Quantitation
Chromatographic purity
99.85%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Read report detailsOriginal certificate (PDF)

Tirzepatide 60mg

Lot in our record: TIR-20260811-01 · Certificate COA7921

Issued 2026-08-23

2 additional laboratory results for this lot

Bioviridian Inc. · COA7921

Reported identity
Tirzepatide
LC-MS/MS
Measured content / assay
61.23 mg
HPLC Quantitation
Chromatographic purity
99.86%
RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Additional laboratory results (2)

Krause Analytical LLC · sample 59abg6p · Lab #214172

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code 59abg6p. We list this result under lot TIR-20260811-01.

Chromatographic purity
>99.9%
Method: HPLC-UV/MS
Measured content
63.6 mg
Method: HPLC-UV-MS
Identity (mass spectral match)
ID Confirmed
Method: HPLC-UV-MS
Label claim
60 mg
% of label, as printed
106.0
COC#
145871
Received
2026-09-18
Analyzed
2026-09-24
Report issued
2026-10-01
Laboratory address
8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director
Mark C. Krause
PDF SHA-256
8b2661825c8ae4ea405746eca21d5705db3a52e145376b26963a4a789961218e
Original full certificate (PDF) · 59abg6p

Krause Analytical LLC · sample fwpftwh · Lab #214173

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code fwpftwh. We list this result under lot TIR-20260811-01.

Chromatographic purity
>99.9%
Method: HPLC-UV/MS
Measured content
60.5 mg
Method: HPLC-UV-MS
Identity (mass spectral match)
ID Confirmed
Method: HPLC-UV-MS
Label claim
60 mg
% of label, as printed
100.9
COC#
145871
Received
2026-09-18
Analyzed
2026-09-24
Report issued
2026-10-01
Laboratory address
8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director
Mark C. Krause
PDF SHA-256
49d92f213eb97864bcebb5c932e0325ceb56616fefdd97eeb34144ca7d885af7
Original full certificate (PDF) · fwpftwh
Read report detailsOriginal certificate (PDF)

Published by Purely Peptides, a commercial research-material supplier. These documentation pages do not establish suitability for human or veterinary use.